Editorial Policy

These are the principles that govern what Clinical Research Data Management Guide publishes. They apply to everything on the site, including coverage of QuesGen, the product developed by our publisher.

Clinical Research Data Management Guide begins with a conviction: clinical research is one of the most consequential things a society does, and everything it produces — every approval, every guideline, every changed practice — rests on the quality of its data. The data managers, research coordinators, investigators, informaticians, monitors, and statisticians who safeguard that quality every day do essential and often invisible work. We built this publication because that work deserves serious attention.

That conviction is not a commercial program, and it does not commit us to any product, platform, or way of working. Practices, standards, funding models, technologies, and study designs deserve to be examined on their individual merits — their evidence, effectiveness, cost, regulatory fit, implementation burden, unintended consequences, demands on site and staff capacity, and the experience of the participants and teams they touch.

We recognize what practitioners already know: running studies is complex, funding research is complex, and no single tool or model fits every study. Reasonable people disagree about how research should be designed, funded, operated, and evaluated — and academic institutions, sponsors, government agencies, site networks, and vendors each play different roles. Our aim is to be a place where those disagreements can be examined honestly: informed discussion, meaningful disagreement, evidence-based debate, and respectful consideration of competing approaches, in service of improving the science and practice of clinical research data management.

We distinguish documented fact from assessment, and assessment from opinion — and when evidence is incomplete, conflicting, or contested, we say so.

When we cover a regulatory, funding, or standards change, we do not begin from "is this good or bad?" We begin from questions a practitioner actually needs answered:

1. What changed?
2. Why did it change?
3. Who is affected?
4. How does implementation work?
5. What evidence exists?
6. What uncertainties exist?
7. What reasonable disagreements or tradeoffs exist?
8. Why does this matter to research teams and the organizations that run studies?

For funding developments specifically, we also work through a standing checklist: the source of funds, amounts where known, recipient types, funding mechanism, restrictions, duration, required reporting and data-sharing obligations, implementation timing, who may gain or lose funding, operational implications for research teams, and open uncertainties.

Some of what we cover is contested. Our approach is to describe regulations, policies, and standards accurately, explain competing rationales, identify the evidence and the tradeoffs, and separate factual effects from interpretation — without advocacy, and without manufacturing false balance when the evidence is clearly one-sided. Where reasonable disagreement genuinely exists, we describe the substance of that disagreement accurately.

Our structural conflict — publisher QuesGen Systems, Inc. develops clinical research data-management technology that competes in the market we cover — is disclosed on the Disclosure page and in the site footer. Editorial decisions — what to cover, what to conclude, how to order and assess products — are made independently of that commercial interest. Any material conflict relevant to a specific piece of content is disclosed on that content, and first-party QuesGen information about QuesGen products is identified as first-party information.

The site currently carries no sponsorship or advertising. If either is introduced in the future, it will be visually and structurally distinguished from editorial content, labelled as such, and will have no influence on editorial decisions, assessments, or conclusions.

Content is editorially reviewed before publication. As the publication develops we intend to involve outside experts and practitioners in review and authorship; contributor involvement and affiliations will be identified when that begins.

We correct substantive errors promptly and annotate materially affected content. Report errors via the Contact page.

The same framework covers our News and Research coverage: when a source, regulation, or policy changes, we update the item and its last-checked date rather than leaving it stale — and we preserve historically important context rather than silently rewriting what was true at the time. Time-sensitive funding and policy items display the date we last checked them.